Eurofins (Paris:ERF) has filed its 2025 Annual Report and its 2025 Environmental, Social and Governance Report for the year ended 31 December 2025 with the electronic database of the Luxembourg Stock ...

Eurofins has launched a consulting offering to support critical innovation across medtech in the U.S. Eurofins Medical Device ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) Cosmetics & Personal Care Testing Business line is the leading provider in cosmetics suncare and personal care testing worldwide, ...

Reported revenues of €3,612m increased year-on-year by 5.7% and reached the highest level achieved by Eurofins in any 6-month period in its history. Organic revenue growth 13 was 3.9% (2.9% excluding ...

Eurofins Rapid Microbiology Laboratories recently announced the launch of its Advanced Learning Institute, a new food safety and quality training division that brings together industry experts and ...

Eurofins is dealing with a revenue decrease due to the lack of COVID testing and the sale of reagents. Excluding the COVID-related revenue, the H1 2023 revenue would have increased by a high single ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Eurofins Scientific SE, the laboratory-testing company facing criticism for its corporate governance, will no longer use an auditor for its Luxembourg subsidiaries who was contemporaneously signing ...

Thanks in part to an investment from Canada’s Strategic Innovation Fund (SIF), Eurofins CDMO is building a new biologics manufacturing facility at its site in Mississauga, Ontario, just outside of ...

EUROFINS SCIENT (ERFSF) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

EUROFINS SCIENT (ERFSF) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Eurofins Launches New U.S. Consulting Chapter in Medtech Strategy & Policy Key Takeaways: Eurofins Medical Eurofins says its ...